C79.32 Secondary malignant neoplasm of cerebral meninges

Name of the Condition

• Secondary Malignant Neoplasm of Cerebral Meninges (ICD Code: C79.32)
• Also known as metastatic meningeal cancer.

Summary

• This condition refers to cancer that has spread to the meninges, the protective membranes covering the brain and spinal cord, from another part of the body.

Causes

• Typically results from primary cancers located elsewhere in the body, such as lung, breast, or melanoma, that metastasize to the brain's meninges.

Risk Factors

• Presence of a primary cancer with a high likelihood of metastasis.
• Advanced stage cancer with systemic dissemination.
• Certain aggressive cancers like melanoma increase risk.

Symptoms

• Headaches
• Neurological deficits like vision or balance problems
• Seizures
• Changes in mental status or cognition

Diagnosis

• MRI or CT scans to identify lesions on the meninges.
• Lumbar puncture for cerebrospinal fluid analysis.
• Biopsy in some cases to confirm malignancy.

Treatment Options

• Radiation Therapy: Targets cancerous cells to reduce size and symptoms.
• Chemotherapy: Systemic or intrathecal to halt cancer spread.
• Surgery: In rare instances, to remove accessible meningeal tumors.
• Supportive care: To manage symptoms effectively.

Prognosis and Follow-Up

• Prognosis can vary depending on the primary cancer type and overall health.
• Regular follow-ups are crucial to monitor tumor progression and response to treatment.

Complications

• Progressive neurological decline.
• Increased intracranial pressure leading to severe complications if untreated.

Lifestyle & Prevention

• While preventing metastasis can be challenging, managing the primary cancer aggressively may help reduce risk.
• Healthy lifestyle choices like a balanced diet and regular exercise may contribute to overall cancer management.

When to Seek Professional Help

• Seek medical advice if experiencing persistent headaches, neurological changes, or symptoms indicative of increased intracranial pressure.

Additional Resources

• American Cancer Society
• National Brain Tumor Society
• Cancer support groups and forums

Tips for Medical Coders

• Ensure the primary malignancy is also coded when documenting secondary meningeal neoplasm.

• Double-check for differentiating primary meningeal neoplasms (e.g., meningioma) from secondary.

• Common coding errors to avoid:

  • Failing to specify the primary site of cancer.
  • Confusing primary CNS neoplasms with metastatic involvement.